SMPL
New Delhi [India], November 16: eMedica, created by visionary innovator Hemant Rohera, Founder of Rohera Health Care Pvt Ltd, is a pioneering medical device that transforms healthcare by leveraging advanced technology to correct the body's electrical parameters, enhances organ functionality, and strengthen immunity. Designed to support natural healing, eMedica provides a non-invasive solution without the risk of side effects, making it a groundbreaking addition to modern medicine.
This innovative device has demonstrated exceptional results in clinical trials conducted at the Government Hospital, Amravati, Sion Hospital Mumbai, Cama Hospital Mumbai effectively addressing major health challenges like COVID-19, Diabetes, Arthritis, Parkinsons, Cancer, PCOD, Thyroid, Paralysis and Hypertension. Its efficacy has been ethically validated by prestigious institutions such as the DMER Directorate of Medical Education Research Mumbai, Apollo Hospitals, and Arogya Bhavan Mumbai.
Endorsements By ICMR, Nanavati Hospital, Cama Hospital, Sion Hospital and Multiple Hospitals and Clincs (Individual Doctors)
Covered with Data Base around 12000 patients
eMedica stands out as a certified and trusted medical device with accreditations from globally recognized bodies, including the FDA, CDSO, ISO, CE, NABL and ROHS. These certifications affirm its safety, reliability, and effectiveness in improving health outcomes.
Supported by publications in esteemed medical journals, eMedica cutting-edge technology has gained recognition for advancing the field of modern healthcare. With its ability to enhance immunity, improve organ functions, and restore the body's natural balance, eMedica is suitable for people of all ages, making it a revolutionary tool for better patient care.
As healthcare evolves to focus more on non-invasive and side-effect-free solutions, eMedica emerges as a beacon of hope, transforming lives and setting a new standard in medical innovation.
For more information visit: https://linktr.ee/eMedica.in
Website: www.emedica.in
(ADVERTORIAL DISCLAIMER: The above press release has been provided by SMPL.will not be responsible in any way for the content of the same)
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor